| Cat.#: 28014 |
| Product Name: Anti-CD70 (Vorsetuzumab) Monoclonal Antibody |
| Synonyms: CD70;CD27L;CD27LG;TNFSF7 |
| Description: Anti-CD70 (vorsetuzumab ) Monoclonal Antibody |
| Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Applications: ELISA; Flow Cyt |
| Recommended Dilutions: ELISA 1:5000-10000; Flow Cyt 1:100 |
| Host Species: Homo sapiens |
| Isotype: IgG1 |
| Purification: Purified from cell culture supernatant by affinity chromatography |
| Species Reactivity: Human CD70 |
| Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
| Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
Figure 1 . ELISA plate pre-coated by 2 µg/ml (100 µl/well) Human CD70, mFc-His tagged protein 11168 can bind Anti-CD70 Neutralizing antibody in a linear range of 3.91-139.9 ng/ml. | 
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD70 (A) were surface stained with anti-CD70 neutralizing antibody 1µg/ml (vorsetuzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody. |
|
